Director Greene buys 962 shares at $26.00 as stock slides 87.5% from $49.60 high; 5 insiders buy within 14 days.
Greene Rick S., a director, purchased 962 shares at $26.00 on 2025-05-08, bringing his holdings to 2,066 shares—an 87.1% increase from his prior 1,104 shares. This transaction occurs while HCW Biologics trades at $6.18 current price, down 87.5% from its 52-week high of $49.60 and down 68.3% over the past 90 days. The company is unprofitable with a net loss of $3,902,288.00 in its most recent fiscal year and declining revenue (-9.7% annual growth). A cluster pattern of 5 other insiders buying within the past 14 days signals coordinated insider accumulation during a period of severe price deterioration. The multi-director buy activity provides a rare signal of insider conviction at highly depressed valuations, though the company's negative profitability and revenue decline warrant careful investor scrutiny of the underlying business trajectory.